| Product Code: ETC11530735 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Companion Diagnostic Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Companion Diagnostic Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Companion Diagnostic Market - Industry Life Cycle |
3.4 Israel Companion Diagnostic Market - Porter's Five Forces |
3.5 Israel Companion Diagnostic Market Revenues & Volume Share, By Technology Type, 2021 & 2031F |
3.6 Israel Companion Diagnostic Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Israel Companion Diagnostic Market Revenues & Volume Share, By Disease Area, 2021 & 2031F |
3.8 Israel Companion Diagnostic Market Revenues & Volume Share, By Sample Type, 2021 & 2031F |
3.9 Israel Companion Diagnostic Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Israel Companion Diagnostic Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases in Israel |
4.2.2 Growing emphasis on personalized medicine and targeted therapies |
4.2.3 Technological advancements in diagnostic testing capabilities |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for companion diagnostics |
4.3.2 Limited reimbursement policies for companion diagnostic tests |
5 Israel Companion Diagnostic Market Trends |
6 Israel Companion Diagnostic Market, By Types |
6.1 Israel Companion Diagnostic Market, By Technology Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Companion Diagnostic Market Revenues & Volume, By Technology Type, 2021 - 2031F |
6.1.3 Israel Companion Diagnostic Market Revenues & Volume, By PCR-Based, 2021 - 2031F |
6.1.4 Israel Companion Diagnostic Market Revenues & Volume, By Immunohistochemistry, 2021 - 2031F |
6.1.5 Israel Companion Diagnostic Market Revenues & Volume, By Next-Gen Sequencing, 2021 - 2031F |
6.1.6 Israel Companion Diagnostic Market Revenues & Volume, By Mass Spectrometry, 2021 - 2031F |
6.2 Israel Companion Diagnostic Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Israel Companion Diagnostic Market Revenues & Volume, By Drug Response Testing, 2021 - 2031F |
6.2.3 Israel Companion Diagnostic Market Revenues & Volume, By Biomarker Testing, 2021 - 2031F |
6.2.4 Israel Companion Diagnostic Market Revenues & Volume, By Genetic Testing, 2021 - 2031F |
6.2.5 Israel Companion Diagnostic Market Revenues & Volume, By Disease Identification, 2021 - 2031F |
6.3 Israel Companion Diagnostic Market, By Disease Area |
6.3.1 Overview and Analysis |
6.3.2 Israel Companion Diagnostic Market Revenues & Volume, By Oncology, 2021 - 2031F |
6.3.3 Israel Companion Diagnostic Market Revenues & Volume, By Cardiology, 2021 - 2031F |
6.3.4 Israel Companion Diagnostic Market Revenues & Volume, By Neurology, 2021 - 2031F |
6.3.5 Israel Companion Diagnostic Market Revenues & Volume, By Rare Diseases, 2021 - 2031F |
6.4 Israel Companion Diagnostic Market, By Sample Type |
6.4.1 Overview and Analysis |
6.4.2 Israel Companion Diagnostic Market Revenues & Volume, By Blood, 2021 - 2031F |
6.4.3 Israel Companion Diagnostic Market Revenues & Volume, By Tissue, 2021 - 2031F |
6.4.4 Israel Companion Diagnostic Market Revenues & Volume, By Saliva, 2021 - 2031F |
6.4.5 Israel Companion Diagnostic Market Revenues & Volume, By Urine, 2021 - 2031F |
6.5 Israel Companion Diagnostic Market, By End User |
6.5.1 Overview and Analysis |
6.5.2 Israel Companion Diagnostic Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.5.3 Israel Companion Diagnostic Market Revenues & Volume, By Diagnostic Centers, 2021 - 2031F |
6.5.4 Israel Companion Diagnostic Market Revenues & Volume, By Research Institutes, 2021 - 2031F |
6.5.5 Israel Companion Diagnostic Market Revenues & Volume, By Pharmaceuticals, 2021 - 2031F |
7 Israel Companion Diagnostic Market Import-Export Trade Statistics |
7.1 Israel Companion Diagnostic Market Export to Major Countries |
7.2 Israel Companion Diagnostic Market Imports from Major Countries |
8 Israel Companion Diagnostic Market Key Performance Indicators |
8.1 Adoption rate of personalized medicine in Israel |
8.2 Number of partnerships between diagnostic companies and pharmaceutical firms |
8.3 Investment in research and development for companion diagnostics. |
9 Israel Companion Diagnostic Market - Opportunity Assessment |
9.1 Israel Companion Diagnostic Market Opportunity Assessment, By Technology Type, 2021 & 2031F |
9.2 Israel Companion Diagnostic Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Israel Companion Diagnostic Market Opportunity Assessment, By Disease Area, 2021 & 2031F |
9.4 Israel Companion Diagnostic Market Opportunity Assessment, By Sample Type, 2021 & 2031F |
9.5 Israel Companion Diagnostic Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Israel Companion Diagnostic Market - Competitive Landscape |
10.1 Israel Companion Diagnostic Market Revenue Share, By Companies, 2024 |
10.2 Israel Companion Diagnostic Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here